PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $42 | 0.0% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $42 | -99.8% | 4,000 | 0.0% | 0.01% | +125.0% |
| Q3 2022 | $18,000 | +12.5% | 4,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $16,000 | -44.8% | 4,000 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $29,000 | +31.8% | 4,000 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $22,000 | -15.4% | 4,000 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $26,000 | -38.1% | 4,000 | -20.0% | 0.01% | -37.5% |
| Q2 2021 | $42,000 | -19.2% | 5,000 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $52,000 | -23.5% | 5,000 | +25.0% | 0.01% | -23.1% |
| Q4 2020 | $68,000 | – | 4,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |